Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eden C. Payabyab
Circulating Tumor DNA as an Early Indicator of Response to T-Cell Transfer Immunotherapy in Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Circulating Tumor DNA to Monitor Treatment Response and Detect Acquired Resistance in Patients With Metastatic Melanoma
Oncotarget
Oncology
Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer
Scientific Reports
Multidisciplinary
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
Cancers
Cancer Research
Oncology
Defining T Cell States Associated With Response to Checkpoint Immunotherapy in Melanoma
Cell
Biochemistry
Genetics
Molecular Biology
Circulating Tumour DNA for Monitoring Treatment Response to Anti-Pd-1 Immunotherapy in Melanoma Patients
Acta Dermato-Venereologica
Dermatology
Medicine
Durable Complete Response From Metastatic Melanoma After Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
Cancer immunology research
Cancer Research
Immunology
P3.04-11 the Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Eruptive Squamous Cell Carcinomas in Metastatic Melanoma: An Unintended Consequence of Immunotherapy
JAAD Case Reports
Dermatology
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
JAMA Oncology
Cancer Research
Oncology
